A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy

Medical Hypotheses

Volumn 73, Issue 3, 2009, Pages 435-437

  Caccavale, Antonio ^a   Imparato, Manuela ^a   Romanazzi, Filippo ^a   Negri, Angelo ^a   Porta, Alessandro ^a   Ferentini, Fabio ^a  

^a C Cantù Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CENTRAL SEROUS RETINOPATHY; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; FEMALE; FIBRINOLYSIS; HUMAN; LITERATURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; THROMBOCYTE AGGREGATION; TREATMENT DURATION; VISUAL ACUITY;

ASPIRIN; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MALE; RETINAL DISEASES; TREATMENT OUTCOME;

EID: 67649576272     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.03.036     Document Type: Article

References (39)

1. Kitzmann A.S., Pulido J.S., Diehl N.N., Hodge D.O., and Burke J.P. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 115 1 (2008) 169-173
2. Hussain D., and Gass J.D. Idiopathic central serous chorioretinopathy. Indian J Ophthalmol 46 3 (1998) 131-137
3. Moon S.J., and Mieler W.F. Retinal complications of bone marrow and solid organ transplantation. Curr Opin Ophthalmol 14 6 (2003) 433-442
4. Kian-Ersi F., Taheri S., and Akhlaghi M.R. Ocular disorders in renal transplant patients. Saudi J. Kidney Dis Transpl. 19 5 (2008) 751-755
5. Shah V.A., Randhawa S., Boldt H.C., and Lee A.G. Central serous chorioretinopathy in giant cell arteritis. Semin Ophthalmol 21 1 (2006) 45-48
6. Haimovici R., Koh S., Gagnon D.R., Lehrfeld T., Wellik S., and Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111 2 (2004) 244-249
7. Carvalho-Recchia C.A., Yannuzzi L.A., Negrão S., et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 109 10 (2002) 1834-1847
8. Schultz K.L., Birnbaum A.D., and Goldstein D.A. Ocular disease in pregnancy. Curr Opin Ophthalmol 16 5 (2005) 308-314
9. Cotticelli L., Borrelli M., D'Alessio A.C., et al. Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 16 2 (2006) 274-278
10. Giusti C., and Mauget-Faÿsse M. Helicobacter pylori and idiopathic central serous chorioretinopathy. Swiss Med Wkly 134 27-28 (2004) 395-398
11. Giusti C. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 63 3 (2004) 524-527
12. Mauget-Faÿsse M., Kodjikian L., Quaranta M., et al. Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study. J Fr Ophtalmol 25 10 (2002) 1021-1025
13. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous chorioretinopathy. Am J Ophthalmol 63 (1967) 587-615
14. Gass J.D.M. Pathogenesis of disciform detachment of the neuroepitheliumI. General concepts and classification. Am J Ophthalmol 63 (1967) 573-585
15. Prünte C., and Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121 1 (1996) 26-34
16. Hirami Y., Tsujikawa A., Sasahara M., et al. Alterations of retinal pigment epithelium in central serous chorioretinopathy. Clin Exp Ophthalmol 35 3 (2007) 225-230
17. Iida T., Kishi S., Hagimura N., and Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19 6 (1999) 508-512
18. Kitaya N., Nagaoka T., Hikichi T., et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Brit J Ophthalmol 87 6 (2003) 709-712
19. Okushiba U., and Takeda M. Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography. Nippon Ganka Gakkai Zasshi 101 1 (1997) 74-82
20. Menchini U., Virgili G., Lanzetta P., and Ferrari E. Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC. Int Ophthalmol 21 2 (1997) 57-69
21. Giovannini A., Scassellati-Sforzolini B., D'Altobrando E., Mariotti C., Rutili T., and Tittarelli R. Choroidal findings in the course of idiopathic serous pigment epithelium detachment detected by indocyanine green videoangiography. Retina 17 4 (1997) 286-293
22. Guyer D.R., Yannuzzi L.A., Slakter J.S., Sorenson J.A., Ho A., and Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112 8 (1994) 1057-1062
23. Lafaut B.A., Salati C., Priem H., and De Laey J.J. Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp 236 7 (1998) 513-521
24. Haimovici R., Rumelt S., and Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110 4 (2003) 698-703
25. Tewari H.K., Gadia R., Kumar D., Venkatesh P., and Garg S.P. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophth Vis Sci 47 8 (2006) 3474-3478
26. Yamada R., Yamada S., Ishii A., and Tane S. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi 97 8 (1993) 955-960
27. Revelo M.P., Federspiel C., Helderman H., and Fogo A.B. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma. Nephrol Dial Transplant 20 12 (2005) 2812-2819
28. He G., Pedersen S.B., Bruun J.M., and Richelsen B. Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen. Horm Metab Res 32 11-12 (2000) 515-520
29. Wickert L., Chatain N., Kruschinsky K., and Gressner A.M. Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes. Comp Hepatol 2 6 (2007) 5
30. Sartori M.T., Serena A., Saggiorato G., et al. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders. J Thromb Haemost 6 2 (2008) 352-358
31. Keates A.C., Tummala S., Peek Jr. R.M., et al. Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun 76 9 (2008) 3992-3999
32. Räikkönen K., Lassila R., Keltikangas-Järvinen L., and Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscl Throm Vas 16 3 (1996) 363-367
33. Tsai S.J., Hong C.J., Liou Y.J., Yu Y.W., and Chen T.J. Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response. Pharmacogenet Genomics 18 10 (2008) 869-875
34. Iijima H., Iida T., Murayama K., Imai M., and Gohdo T. Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol 127 4 (1999) 477-478
35. Jastrzebska M., Torbus-Lisiecka B., Pieczul-Mróz J., and Chełstowski K. Evaluation of platelet function and tissue plasminogen activator activity in ischemic heart disease depending on concurrence with hyperlipoproteinemia and aspirin therapy. Pol Arch Med Wewn 98 12 (1997) 510-519
36. Tohgi H., Takahashi H., Chiba K., and Tamura K. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication. Stroke 24 6 (1993) 801-804
37. Pikkel J., Beiran I., Ophir A., and Miller B. Acetazolamide for central serous retinopathy. Ophthalmology 109 9 (2002) 1723-1725
38. Levy J., Marcus M., Belfair N., Klemperer I., and Lifshitz T. Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy. Can J Ophthalmol 40 2 (2005) 217-221
39. Chaine G., Haouat M., Menard-Molcard C., et al. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophtalmol 24 2 (2001) 139-146